S&P 500

5.431,60

-0,04%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Melinta Therapeutics Inc (MLNT)
Melinta Therapeutics Inc (MLNT) Notícias

MLNT

Melinta Therapeutics (MLNT)

Melinta Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:MLNT

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
24/06/2020	17:02	GlobeNewswire Inc.	Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of Tetraphase	NASDAQ:MLNT	Melinta Therapeutics Inc
09/06/2020	17:02	GlobeNewswire Inc.	Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals	NASDAQ:MLNT	Melinta Therapeutics Inc
04/03/2020	18:03	GlobeNewswire Inc.	Melinta Therapeutics Confirms Deerfield as Successful Bidder for Company	NASDAQ:MLNT	Melinta Therapeutics Inc
13/02/2020	18:02	GlobeNewswire Inc.	Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding Procedures	NASDAQ:MLNT	Melinta Therapeutics Inc
05/02/2020	13:15	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:MLNT	Melinta Therapeutics Inc
08/01/2020	18:39	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLNT	Melinta Therapeutics Inc
27/12/2019	11:02	GlobeNewswire Inc.	Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit Facility	NASDAQ:MLNT	Melinta Therapeutics Inc
12/11/2019	19:07	GlobeNewswire Inc.	Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019	NASDAQ:MLNT	Melinta Therapeutics Inc
12/11/2019	19:00	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MLNT	Melinta Therapeutics Inc
25/10/2019	13:54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MLNT	Melinta Therapeutics Inc
24/10/2019	17:02	GlobeNewswire Inc.	Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Tr...	NASDAQ:MLNT	Melinta Therapeutics Inc
01/10/2019	11:07	PR Newswire (US)	Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019	NASDAQ:MLNT	Melinta Therapeutics Inc
03/09/2019	17:05	GlobeNewswire Inc.	Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director	NASDAQ:MLNT	Melinta Therapeutics Inc
13/08/2019	07:02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:MLNT	Melinta Therapeutics Inc
09/08/2019	08:31	GlobeNewswire Inc.	Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan	NASDAQ:MLNT	Melinta Therapeutics Inc
09/08/2019	08:30	GlobeNewswire Inc.	Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update	NASDAQ:MLNT	Melinta Therapeutics Inc
06/08/2019	18:04	GlobeNewswire Inc.	Melinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results Reporting	NASDAQ:MLNT	Melinta Therapeutics Inc
16/07/2019	08:30	GlobeNewswire Inc.	Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update	NASDAQ:MLNT	Melinta Therapeutics Inc
10/07/2019	16:00	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:MLNT	Melinta Therapeutics Inc
01/07/2019	10:13	PR Newswire (US)	X-Biotix Therapeutics Joins Antimicrobials Working Group	NASDAQ:MLNT	Melinta Therapeutics Inc
26/06/2019	17:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLNT	Melinta Therapeutics Inc
20/06/2019	12:13	PR Newswire (US)	Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2019	NASDAQ:MLNT	Melinta Therapeutics Inc
19/06/2019	08:30	GlobeNewswire Inc.	Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the ...	NASDAQ:MLNT	Melinta Therapeutics Inc
07/06/2019	10:27	PR Newswire (US)	Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Inno...	NASDAQ:MLNT	Melinta Therapeutics Inc
16/05/2019	18:31	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:MLNT	Melinta Therapeutics Inc
09/05/2019	17:00	GlobeNewswire Inc.	Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update	NASDAQ:MLNT	Melinta Therapeutics Inc
07/05/2019	08:30	GlobeNewswire Inc.	Melinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual Meeting	NASDAQ:MLNT	Melinta Therapeutics Inc
02/05/2019	17:30	GlobeNewswire Inc.	Melinta Therapeutics to Report First Quarter 2019 Financial Results on May 9, 2019	NASDAQ:MLNT	Melinta Therapeutics Inc
30/04/2019	07:18	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:MLNT	Melinta Therapeutics Inc
12/04/2019	11:08	PR Newswire (US)	Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology a...	NASDAQ:MLNT	Melinta Therapeutics Inc